Nigel Thompson

Nigel Thompson is a Senior Advisor at ASG, where he draws on thirty years of experience in international pharmaceutical markets to help clients navigate the regulatory environment of the pharmaceutical industry around the world. Mr. Thompson specializes in economic strategy, pricing and reimbursement, government relations, and business development. He works closely with ASG’s Health practice. Mr. Thompson is also the President of Parks Pharma Consulting.

Previously, he was the Executive Director of Economic and Development Strategy at Merck. During his tenure at Merck, he played an active role in designing and implementing strategies to accelerate and protect market access in European and emerging markets.

Mr. Thompson also served as the Pharmaceutical Advisor to the World Bank from the International Federation of Pharmaceutical Manufacturers and Associations. In this capacity, he advised the World Bank on pharmaceutical issues in emerging markets and developed dialogues between pharmaceutical companies and the World Bank.

He is also a British Chartered Accountant. Mr. Thompson is fluent in French.

He is based in New York City. 


A global team of respected professionals

The ASG family will forever be grateful for our dear friends, former Secretary of State Madeleine K. Albright and firm co-founder and co-chair Samuel R. “Sandy” Berger.

Partner Firms



                                                             LYNX Strategic Business Advisors